235. 副甲状腺機能低下症
[臨床試験数:67,薬物数:112(DrugBank:24),標的遺伝子数:4,標的パスウェイ数:5

Searched query = "Hypoparathyroidism", "Accessory thyroid hypergasia disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2015-003108-22-GB
(EUCTR)
08/12/201526/10/2015Study on parathyroid hormone for use in hypoparathyroidism in children 12 to less than 18 years old.An Open-label, Single-dose Study to Determine the Pharmacokinetic/Pharmacodynamic Profile of Parathyroid Hormone (rDNA) Administered Subcutaneously at a Dose of50 µg in Subjects with Hypoparathyroidism Who Are 12 to LessThan 18 Years of Age Chronic hypoparathyroidism;Therapeutic area: Diseases [C] - Hormonal diseases [C19]Product Name: Parathyroid Hormone (rDNA)
Product Code: NPSP 558
INN or Proposed INN: INN Parathyroid Hormone (1-84) human
Other descriptive name: Parathyroid Hormone (1-84) Human Recombinant
NPS Pharmaceuticals, Inc.NULLNot RecruitingFemale: yes
Male: yes
10Phase 1United Kingdom
2EUCTR2008-000606-36-DK
(EUCTR)
07/04/200825/03/2008Treatment of hypoparathyroidism with subcutaneous PTH (1-84) injections: effects on muscle function and quality of life - HypoPTTreatment of hypoparathyroidism with subcutaneous PTH (1-84) injections: effects on muscle function and quality of life - HypoPT Hypoparathyroidism
MedDRA version: 9.1;Level: LLT;Classification code 10021041;Term: Hypoparathyroidism
Trade Name: Preotact
Product Name: parathyroid hormone (rdna)
Product Code: SUB21634
INN or Proposed INN: Parathyroideahormon
Aarhus University Hospital, Dept of Endocrinology and Metabolism CNULLNot RecruitingFemale: yes
Male: yes
60Denmark